• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nevro Corp (NY: NVRO )

    8.230 -0.130 (-1.56%)
    Streaming Delayed Price Updated: 1:53 PM EDT, Jun 28, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 153,838
    Open 8.420
    Bid (Size) 8.210 (2)
    Ask (Size) 8.230 (2)
    Prev. Close 8.360
    Today's Range 8.080 - 8.500
    52wk Range 7.850 - 26.53
    Shares Outstanding 35,817,154
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Assessing Nevro: Insights From 9 Financial Analysts
    Via Benzinga
    NVRO Stock Earnings: Nevro Beats EPS, Beats Revenue for Q1 2024
    NVRO stock results show that Nevro beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace

    Performance

    YTD
    -60.36%
    -60.36%
    1 Month
    -13.55%
    -13.55%
    3 Month
    -43.01%
    -43.01%
    6 Month
    -62.74%
    -62.74%
    1 Year
    -68.13%
    -68.13%

    More News

    Read More
    Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off
    Via AB Newswire
    Where Nevro Stands With Analysts
    Via Benzinga
    Why Nevro Stock Lagged the Market on Thursday
    Via The Motley Fool
    Analyst Scoreboard: 4 Ratings For Nevro
    Via Benzinga
    Nevro: Q4 Earnings Insights
    Via Benzinga
    Earnings Scheduled For February 21, 2024
    Via Benzinga
    What Analysts Are Saying About Nevro Stock
    Via Benzinga
    Forecasting The Future: 6 Analyst Projections For Nevro
    Via Benzinga
    Where Nevro Stands With Analysts
    Via Benzinga
    What 4 Analyst Ratings Have To Say About Nevro
    Via Benzinga
    Earnings Preview For Nevro
    Via Benzinga
    What 21 Analyst Ratings Have To Say About Nevro
    Via Benzinga
    Expert Ratings for Nevro
    Via Benzinga
    Why Shares of Nevro Are Down Wednesday
    Via The Motley Fool
    Potential Turnaround Ahead for Nevro: Q2 Earnings, Guidance Lag Wall Street Estimates
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    What 17 Analyst Ratings Have To Say About Nevro
    Via Benzinga
    Uncertainties In Nevro's Core Business Lead To Revised FY24 Projections By Oppenheimer Analyst
    Via Benzinga
    Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For July 19, 2023
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Via Benzinga
    Why THOR Industries Shares Are Trading Higher By 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.